SCHEMBL8314965

SCHEMBL8314965

CC(C)(C)c1csc(-c2cc3cc(OCc4cccc(-c5nnn[nH]5)c4)ccc3o2)n1

nearest known ligand 0.35

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
F2RL3 Q96RI0 3/20 0.35
MAOB P27338 6/20 0.34
HIF1A Q16665 1/20 0.33
ANO1 Q5XXA6 3/20 0.32
APP P05067 1/20 0.31
MRGPRX4 Q96LA9 1/20 0.31
ALOX5 P09917 1/20 0.31
CYP26A1 O43174 1/20 0.30
CYP26B1 Q9NR63 1/20 0.30
PTPN1 P18031 1/20 0.30
PTPN12 Q05209 1/20 0.30
PTPN22 Q9Y2R2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6597036 0.83 CNR1 (0.33) MAOB
SCHEMBL8316231 0.79 MAOB (0.46) F2RL3MAOB
SCHEMBL8310428 0.79 F2RL3 (0.33) F2RL3
SCHEMBL8316881 0.79 MRGPRX4 (0.52) MRGPRX4
Water SCHEMBL8314845 0.79 F2RL3 (0.32) F2RL3
SCHEMBL8314160 0.77 MRGPRX4 (0.48) MAOBMRGPRX4CYP26A1
SCHEMBL6599726 0.77 F2RL3 (0.31) F2RL3
SCHEMBL7472096 0.77 F2RL3 (0.32) F2RL3
SCHEMBL8315203 0.75 PDE9A (0.31) MAOBALOX5
SCHEMBL7480046 0.75 F2RL3 (0.31) F2RL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0528337-B1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1999-10-20 EP disclosed
US-5296495-A Antiallergens, antiinflammatory FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-03-22 US disclosed
EP-0528337-A1 New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-02-24 EP disclosed